Showing results (31-40 of 206) with videos related to

Sort By:
Pageof 21
Drug and Alcohol Dependence|April 2, 2017
Buprenorphine physician supply: Relationship with state-level prescription opioid mortalityHannah K Knudsen, Jennifer R Havens, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|September 14, 2019
US physicians' decision-making during buprenorphine-naloxone treatment: Conjoint analyses of dose and office visit adjustments based on patient progressHannah K Knudsen, Michelle R Lofwall, Lewei Allison Lin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related InfectionsLaura C Fanucchi, Sharon L Walsh, Alice C Thornton, et al.
Journal of Clinical Psychopharmacology|June 15, 2016
A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical TrialsAidan J Hampson, Shanna Babalonis, Michelle R Lofwall, et al.
Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care|December 27, 2023
Get It in Writing: How to Make Medications for Opioid Use Disorder Available During IncarcerationMargaret McGladrey, Jordan Kelsch, Michelle R Lofwall, et al.
Substance Abuse Treatment, Prevention, and Policy|August 18, 2017
A mixed methods study of HIV-related services in buprenorphine treatmentHannah K Knudsen, Jennifer Cook, Michelle R Lofwall, et al.
Drug and Alcohol Dependence|November 17, 2019
Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting systemRachel Vickers-Smith, Jiangwen Sun, Richard J Charnigo, et al.
Substance Abuse Treatment, Prevention, and Policy|April 2, 2025
Barriers and facilitators to scaling up medications for opioid use disorder in Kentucky: qualitative perspectives of treatment organization staffHannah K Knudsen, Shaquita Andrews-Higgins, Sandra Back-Haddix, et al.
Drug and Alcohol Dependence|October 21, 2015
Safety of oral dronabinol during opioid withdrawal in humansCrystal J Jicha, Michelle R Lofwall, Paul A Nuzzo, et al.
Research Square|December 23, 2024
Scaling up medications for opioid use disorder in Kentucky: Qualitative perspectives of treatment organizationsHannah K Knudsen, Shaquita Andrews-Higgins, Sandra Back-Haddix, et al.
Pageof 21